High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.
Wilkinson, I.C., Hall, C.J., Veverka, V., Shi, J.Y., Muskett, F.W., Stephens, P.E., Taylor, R.J., Henry, A.J., Carr, M.D.(2009) J Biol Chem 284: 31928-31935
- PubMed: 19776018 
- DOI: 10.1074/jbc.M109.025304
- Primary Citation of Related Structures:  
2KH2 - PubMed Abstract: 
Monoclonal antibodies have recently started to deliver on their promise as highly specific and active drugs; however, a more effective, knowledge-based approach to the selection, design, and optimization of potential therapeutic antibodies is currently limited by the surprising lack of detailed structural information for complexes formed with target proteins ...